For research use only. Not for therapeutic Use.
Brexpiprazole-d8(CAT: C000072) is a deuterium-labeled derivative of Brexpiprazole, a pharmaceutical compound used primarily in the field of psychiatry. Brexpiprazole is an antipsychotic medication approved for the treatment of schizophrenia and major depressive disorder. The deuterium-labeled version, Brexpiprazole-d8, is used in pharmacological and clinical studies to track the drug’s metabolism and distribution in the body.
| Catalog Number | C000072 |
| CAS Number | 1427049-19-1 |
| Synonyms | 7-[4-(4-(Benzo[b]thien-4-yl)-piperazin-1-yl)butoxy]-1H-quinolin-2-one-d8; OPC 34712-d8 |
| Molecular Formula | C₂₅H₁₉D₈N₃O₂S |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| Solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) |
| Appearance | White to Beige Solid |
| Storage | 4°C |
| Reference | Yamashita, H., et al.: PCT Int. Appl., WO 2006112464 A1 20061026 (2006) |
